CHG Applicator (26mL, 30mL, 35mL & 40mL)

Principle

CHG is a fast-acting, broad spectrum, persistent antiseptic thatsignificantly reduces the number of microorganisms on intact skin. It provide a proven system that supports infection control guidelines for helping to reduce the incidence of BSIs and SSIs.

CHG maintains a persistent antimicrobial function by disrupting the cell membrane and precipitating their contents. IPA quickly destroys micro-organisms by denaturing cell proteins, giving significant defense against broad-spectrum micro-organisms and rapid bactericidal action and keeps fighting bacteria for at least 48 hours.

Guideline

CHG Prepping Products with formulation of 2% chlorhexidine gluconate (CHG) and 70% isopropyl alcohol (IPA) patient preoperative skin preparation to meet US CDC strict clinical requirements for a New Drug Application (NDA), kills more bacteria than traditional iodophors or alcohol.

Other Antiseptic Solution Composition (Customizable)

• 0.5% wƒv CHG ( ChIorhexidine GIuconate ) + 70% vƒv IPA (IsopropyI AIcohoI)
• 3.15% wƒv CHG ( ChIorhexidine GIuconate ) + 70% vƒv IPA (IsopropyI AIcohoI)
• 4.0% wƒv CHG ( ChIorhexidine GIuconate ) + 70% vƒv IPA (IsopropyI AIcohoI)
• Povidone Iodine USP 10% wƒv (EquivaIent to 1% TitratabIe Iodine)

Instructions for Use

Specification

Advantages

1. More effective at reducing skin bacteria than other antiseptics.

2. Exhibits a rapid & persistent bactericidal activity without irritating the skin Active in proteinrich biomaterials.

3. Latex-free, does not contain DEHP .

Function Area

• CY-030-CHG(3mL)provide approximately 2.8″ x 2.8″ coverage area.
• CY-050-CHG(5mL)provide approximately 4″ x 4″ coverage area.
• CY-060-CHG(6mL)provide approximately 4″ x 5″ coverage area.
• CY-105-CHG(10.5mL)provide approximately 8″ x 8″ coverage area.
• CY-260-CHG(26mL)provide approximately 13.2″ x 13.2″ coverage area.

Applications of CHG Applicator

• Pre-injection & Preoperative Procedure.
• Peripheral lV insertions and restarts.
• Dialysis procedures Routine venipunctures.
• Percutaneous device insertions Simple biopsies.
• Vascular Access Insertion & Maintenance.
• Routine catheter maintenance Arterial blood gas collections.
• surgical site cleansing after suturing.
• Arterial venous fistulas (AVF)/arterial-venous graphs (AVG).